These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 10864035)
21. High-dose methotrexate as part of remission maintenance therapy for childhood acute lymphocytic leukemia: a Pediatric Oncology Group pilot study. Frankel LS; Wang YM; Shuster J; Nitschke R; Doering EJ; Pullen J J Clin Oncol; 1983 Dec; 1(12):804-9. PubMed ID: 6583318 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of methotrexate in the extracellular fluid of brain C6-glioma after intravenous infusion in rats. Dukic S; Heurtaux T; Kaltenbach ML; Hoizey G; Lallemand A; Gourdier B; Vistelle R Pharm Res; 1999 Aug; 16(8):1219-25. PubMed ID: 10468023 [TBL] [Abstract][Full Text] [Related]
23. Simultaneous Determination of Methotrexate Concentrations in Human Plasma and Cerebrospinal Fluid Using Two-Dimensional Liquid Chromatography: Applications in Primary Central Nervous System Lymphoma. Wang YH; He Q; Wang F; Jiang H; Shi J; Ma J; Liu YG World J Oncol; 2024 Oct; 15(5):825-836. PubMed ID: 39328338 [TBL] [Abstract][Full Text] [Related]
24. Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections. Wright KD; Panetta JC; Onar-Thomas A; Reddick WE; Patay Z; Qaddoumi I; Broniscer A; Robinson G; Boop FA; Klimo P; Ward D; Gajjar A; Stewart CF Cancer Chemother Pharmacol; 2015 Jan; 75(1):27-35. PubMed ID: 25342291 [TBL] [Abstract][Full Text] [Related]
25. Effect of probenecid on cerebrospinal fluid methotrexate kinetics. Howell SB; Olshen RA; Rice JA Clin Pharmacol Ther; 1979 Nov; 26(5):641-6. PubMed ID: 498706 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of methotrexate in the cerebrospinal fluid after intracerebroventricular administration in patients with meningeal carcinomatosis and altered cerebrospinal fluid flow dynamics. Miller KT; Wilkinson DS Ther Drug Monit; 1989; 11(3):231-7. PubMed ID: 2728081 [TBL] [Abstract][Full Text] [Related]
27. Probenecid inhibition of methotrexate-cerebrospinal fluid pharmacokinetics in dogs. Ramu A; Fusner JE; Blaschke T; Glaubiger DL Cancer Treat Rep; 1978 Oct; 62(10):1465-70. PubMed ID: 581360 [TBL] [Abstract][Full Text] [Related]
28. A pharmacokinetic model for predicting the concentration of methotrexate in plasma subsequent to intrathecal injection. Ramu A; Fusner JE Isr J Med Sci; 1979 Jun; 15(6):494-9. PubMed ID: 582316 [TBL] [Abstract][Full Text] [Related]
29. PBPK model of methotrexate in cerebrospinal fluid ventricles using a combined microdialysis and MRI acquisition. Brandhonneur N; Noury F; Bruyère A; Saint-Jalmes H; Le Corre P Eur J Pharm Biopharm; 2016 Jul; 104():117-30. PubMed ID: 27142258 [TBL] [Abstract][Full Text] [Related]
30. Effects of leucovorin (folinic acid) in the methotrexate-treated rat brain. Ogushi N; Sasaki K; Shimoda M J Vet Med Sci; 2018 May; 80(5):760-765. PubMed ID: 29607891 [TBL] [Abstract][Full Text] [Related]
31. Transnasal delivery of methotrexate to brain tumors in rats: a new strategy for brain tumor chemotherapy. Shingaki T; Inoue D; Furubayashi T; Sakane T; Katsumi H; Yamamoto A; Yamashita S Mol Pharm; 2010 Oct; 7(5):1561-8. PubMed ID: 20695463 [TBL] [Abstract][Full Text] [Related]
32. Determination of free extracellular levels of methotrexate by microdialysis in muscle and solid tumor of the rabbit. Dukic S; Kaltenbach ML; Gourdier B; Marty H; Vistelle R Pharm Res; 1998 Jan; 15(1):133-8. PubMed ID: 9487560 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of methotrexate following intravenous and intraventricular administration in acute lymphocytic leukemia and non-Hodgkin's lymphoma. Ettinger LJ; Chervinsky DS; Freeman AI; Creaven PJ Cancer; 1982 Nov; 50(9):1676-82. PubMed ID: 6956429 [TBL] [Abstract][Full Text] [Related]
34. Active transport of methotrexate from cerebrospinal fluid in humans. Bode U; Magrath IT; Bleyer WA; Poplack DG; Glaubiger DL Cancer Res; 1980 Jul; 40(7):2184-7. PubMed ID: 7388786 [TBL] [Abstract][Full Text] [Related]
35. Effect of dose and repeat intravenous 24 hr infusions of methotrexate on cerebrospinal fluid availability in children with hematological malignancies. Thyss A; Milano G; Deville A; Manassero J; Renee N; Schneider M Eur J Cancer Clin Oncol; 1987 Jun; 23(6):843-7. PubMed ID: 3477462 [TBL] [Abstract][Full Text] [Related]
36. Intratumoral methotrexate kinetics in a patient with intracranial anaplastic ependymoma. Geis T; Peters O; Friedrich M; Dränert E; Wolff JE Pediatr Blood Cancer; 2004 Jul; 43(1):78-80. PubMed ID: 15170895 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic study of methotrexate following intra-articular injection of methotrexate loaded poly(L-lactic acid) microspheres in rabbits. Liang LS; Wong W; Burt HM J Pharm Sci; 2005 Jun; 94(6):1204-15. PubMed ID: 15858840 [TBL] [Abstract][Full Text] [Related]
38. In vivo microdialysis to characterize drug transport in brain tumors: analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats. Devineni D; Klein-Szanto A; Gallo JM Cancer Chemother Pharmacol; 1996; 38(6):499-507. PubMed ID: 8823490 [TBL] [Abstract][Full Text] [Related]
39. Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats. Wang F; Jiang X; Lu W Int J Pharm; 2003 Sep; 263(1-2):1-7. PubMed ID: 12954175 [TBL] [Abstract][Full Text] [Related]
40. Interstitial methotrexate kinetics in primary breast cancer lesions. Müller M; Brunner M; Schmid R; Mader RM; Bockenheimer J; Steger GG; Steiner B; Eichler HG; Blöchl-Daum B Cancer Res; 1998 Jul; 58(14):2982-5. PubMed ID: 9679959 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]